OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Annonaceous Acetogenins Synergistically Inhibit Hepatocellular Carcinoma with Sorafenib
Rongsheng Li, Lingyun Li, Xiaofeng Zhu, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 1, pp. 14-27
Closed Access | Times Cited: 6
Rongsheng Li, Lingyun Li, Xiaofeng Zhu, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 1, pp. 14-27
Closed Access | Times Cited: 6
Showing 6 citing articles:
Enhancement of apoptosis in HCT116 and HepG2 cells by Coix lacryma-jobi var. lacryma-jobi seed extract in combination with sorafenib
Supawadee Parhira, Guo‐Yuan Zhu, Apirath Wangteeraprasert, et al.
Chinese Herbal Medicines (2025)
Open Access
Supawadee Parhira, Guo‐Yuan Zhu, Apirath Wangteeraprasert, et al.
Chinese Herbal Medicines (2025)
Open Access
Design and interaction mechanism of novel SIRT1 inhibitors for the treatment of hepatocellular carcinoma
Jing Luo, Xiaomeng Wang, Qiao Fu, et al.
New Journal of Chemistry (2025)
Closed Access
Jing Luo, Xiaomeng Wang, Qiao Fu, et al.
New Journal of Chemistry (2025)
Closed Access
Annonaceae acetogenins: A potential treatment for gynecological and breast cancer
Diego A. Bravo-Alfaro, Efigenia Montalvo‐González, J Martin Zapien-Macias, et al.
Fitoterapia (2024) Vol. 178, pp. 106187-106187
Closed Access | Times Cited: 1
Diego A. Bravo-Alfaro, Efigenia Montalvo‐González, J Martin Zapien-Macias, et al.
Fitoterapia (2024) Vol. 178, pp. 106187-106187
Closed Access | Times Cited: 1
Discovery of Novel PROTAC SIRT6 Degraders with Potent Efficacy against Hepatocellular Carcinoma
Jinbo Huang, Jiajie Su, Haiyu Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17319-17349
Closed Access | Times Cited: 1
Jinbo Huang, Jiajie Su, Haiyu Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17319-17349
Closed Access | Times Cited: 1
Cerbera odollam fruit extracts enhance anti-cancer activity of sorafenib in HCT116 and HepG2 cells
Supawadee Parhira, Orakot Simanurak, Khemmachat Pansooksan, et al.
Chinese Herbal Medicines (2024) Vol. 17, Iss. 1, pp. 108-126
Open Access | Times Cited: 1
Supawadee Parhira, Orakot Simanurak, Khemmachat Pansooksan, et al.
Chinese Herbal Medicines (2024) Vol. 17, Iss. 1, pp. 108-126
Open Access | Times Cited: 1
A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma
Chenicheri K. Keerthana, Sreekumar U. Aiswarya, Tennyson P. Rayginia, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1431-1441
Closed Access
Chenicheri K. Keerthana, Sreekumar U. Aiswarya, Tennyson P. Rayginia, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1431-1441
Closed Access
